Clinical Trials
3 trialsNCT06504615 2026-04-03
METAGIO
Bristol-Myers Squibb
Active not recruiting
NCT04868877 2026-02-19
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination
Merus B.V.
Phase 1/2 Active not recruiting
NCT04229537 2020-01-18
Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC
Sinocelltech Ltd.
Phase 1 Unknown